NCT06089018 Observational Study of Digital Biomarkers of Myotonia and Gait in Adults and Children With Myotonic Dystrophy Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06054893 A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06044337 A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus Status ENROLLING_BY_INVITATION Phase PHASE3
NCT05925049 A Study Utilising Data From European Union (EU) National Multiple Sclerosis (MS) Registries to Assess the Incidence of Anti-Natalizumab Antibody Among Participants Who Receive Subcutaneous Administration of Natalizumab for Treatment of Relapsing-remitting Multiple Sclerosis (RRMS) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05909644 An Open-label DDI Study of Omaveloxolone in Healthy Subjects Status COMPLETED Phase PHASE1
NCT05866419 Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy Status RECRUITING Phase NA
NCT05798520 A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS) Status COMPLETED Phase PHASE2
NCT05789758 A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies Status RECRUITING Phase N/A
NCT05767736 A Study to Evaluate Long-Term Safety of Vumerity and Tecfidera in Participants With Multiple Sclerosis (MS) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05764122 A Study to Evaluate the Efficacy and Safety of BIIB131 for Participants With Ischemic Stroke Between 4.5 and 24 Hours After Last Known Well Status WITHDRAWN Phase PHASE2
NCT05701423 A Study of End of Dose Phenomena in Subcutaneous Natalizumab Treated Multiple Sclerosis (MS) Participants Status TERMINATED Phase N/A
NCT05688436 A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05658497 Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate) Status RECRUITING Phase N/A
NCT05658484 A Study of Dimethyl Fumarate (DMF) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in China Status COMPLETED Phase PHASE4
NCT05655507 Zuranolone Pharmacokinetics (PK) and Safety Study Adolescent Participants With Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE1
NCT05618379 Adult Spinal Muscular Atrophy (SMA) China Registry Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05618301 Motixafortide and Natalizumab to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease (SCD) Status COMPLETED Phase PHASE1
NCT05575011 A Study to Learn About the Safety of BIIB115 Injections and How BIIB115 is Processed in the Bodies of Healthy Adult Male Volunteers and of Pediatric Participants With Spinal Muscular Atrophy Who Previously Took Onasemnogene Abeparvovec Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05561621 Prediction of Non-motor Symptoms in Fully Ambulatory MS Patients Using Vocal Biomarkers Status COMPLETED Phase N/A